Ella Kazerooni, MD, MS
Steering Committee Chair
University of Michigan
Ella A. Kazerooni MD MS is a Professor of Radiology & Internal Medicine, Associate Chair for Clinical Affairs & Director of Cardiothoracic Radiology at the University of Michigan / Michigan Medicine.
With a Master’s degree in Clinical Research Design & Statistical Analysis, her research focuses on the development/ and evaluation of advanced imaging technologies applied to the heart and lungs, including lung cancer screening, coronary artery and aortic disease, pulmonary embolism, and diffuse lung disease. Her work in clinical and translational research earned her the University of Michigan Medical School’s prestigious Clinical and Health Services Researcher of the year award. She has given over 400 lectures, nearly 300 peer-reviewed manuscripts, 30 book chapters and 4 books. She began the Radiology Service Excellence Program at U of M, with the department achieving the highest patient satisfaction scores in the health system. She is a frequently invited speaker on the topics of patient centered care & service excellence, lung cancer screening and lung disease, and is passionate about mentoring and coaching faculty and trainees as clinicians & scientists and as leaders.
A past president of the ARRS, AUR, Society of Thoracic Radiology and the Radiology Alliance for Health Services Research, she is also an immediate past Trustee of the American Board of Radiology and has also served on the ACR Board of Chancellors.
Dr. Kazerooni is the vice Chair of the NCCN Lung Cancer Screening panel, and chairs the ACR Committee on Lung Cancer Screening including the Lung-RADS committee, worked towards the ACR Designated Lung Cancer Screening program under the CT accreditation program, and co-chairs the ACR’s Lung Cancer Screening Registry (LCSR). These efforts are focused on bringing quality lung cancer screening to high risk individuals, and reduce the mortality from the #1 cancer killer. Most recently, she was named the inaugural chair of the American Cancer Society’s National Lung Cancer Roundtable.